Treatment of soft-tissue infections in children with amoxicillin-clavulanic acid combination or cefaclor

W. L. Risser, Sheldon Kaplan, Edward Mason

    Research output: Contribution to journalArticlepeer-review

    2 Scopus citations

    Abstract

    Amoxicillin plus clavulanic acid (A-CA), a combination potentially effective against beta-lactamase-producing bacteria, was compared against cefaclor (C) in a double-blind randomized trial in 91 children (46 A-CA, 45 C) with skin and soft-tissue infections. Types of infections included: moderate to severe impetigo 26, abscess 16, cellulitis 13, and five others affecting 9 subjects. Microorganisms included Staphylococcus aureus 51, Streptococcus pyogenes 24, and 9 isolates of 4 species of Gram-negative bacilli. Clinical cure was achieved in 36 of 37 children (97%) who received A-CA and in all who received C; bacteriologic cure was achieved in all patients. Side effects occurred in 2 children receiving A-CA and 4 receiving C.

    Original languageEnglish (US)
    Pages (from-to)747-753
    Number of pages7
    JournalCurrent Therapeutic Research - Clinical and Experimental
    Volume37
    Issue number4
    StatePublished - Jan 1 1985

    ASJC Scopus subject areas

    • Pharmacology
    • Pharmacology (medical)

    Fingerprint

    Dive into the research topics of 'Treatment of soft-tissue infections in children with amoxicillin-clavulanic acid combination or cefaclor'. Together they form a unique fingerprint.

    Cite this